Collegium Pharmaceutical (COLL)
(Delayed Data from NSDQ)
$35.45 USD
+0.05 (0.14%)
Updated Apr 17, 2024 04:00 PM ET
After-Market: $35.42 -0.03 (-0.08%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth C Momentum A VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/02/2024
Time: -- |
3/2024 | $1.50 | 0.00% |
Earnings Summary
For their last quarter, Collegium Pharmaceutical (COLL) reported earnings of $1.58 per share, beating the Zacks Consensus Estimate of $1.33 per share. This reflects a positive earnings surprise of 18.80%. Look out for COLL's next earnings release expected on May 02, 2024. For the next earning release, we expect the company to report earnings of $1.50 per share, reflecting a year-over-year increase of 13.64%.
Earnings History
Price & Consensus
Zacks News for COLL
Humana (HUM), DUOS Unveil Program to Improve Veterans' Health
COLL: What are Zacks experts saying now?
Zacks Private Portfolio Services